Project Grant R01HD118103
- The National Institute of Child Health and Human Development awarded the University of North Carolina at Chapel Hill $633,868 on August 27, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to examine pathways linking childhood maltreatment to accelerated biological aging and cognitive impairment at midlife. The research investigates how childhood abuse and trauma increase the risk of accelerated biological aging and cognitive decline in adulthood, with...
- The National Institute of Child Health and Human Development awarded the University of Southern California $236,202 on April 9, 2026, under the Child Health and Human Development Extramural Research Program (CFDA 93.865) to conduct research on prenatal and parenting influences on school-age executive function. The research examines separate and joint maternal and paternal contributions to child development from the prenatal period through middle childhood. Aim 1 tests how maternal and paternal...
- The National Institute of Child Health and Human Development awarded The Regents of the University of Colorado, doing business as University of Colorado-Denver, $669,594 on June 17, 2026, under the Child Health and Human Development Extramural Research Projects program (CFDA 93.865) to investigate circulating extracellular vesicles as functional biomarkers of maternal mental and physical health in pregnancy and postpartum, with focus on women with high levels of adverse childhood experiences....
- The National Institute of Child Health and Human Development awarded $100,228 to the University of Southern California on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to support research characterizing brain perivascular space development and its genetic and environmental determinants during early adolescence. The research leverages longitudinal neuroimaging, whole genome sequencing, wearable-derived physical health metrics, and...
- The National Institute of Child Health and Human Development awarded Children's Mercy Hospital $1.907 million on September 15, 2025, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to examine state-level safety net policies and their association with pediatric hospitalizations and reported child maltreatment among low-income families. The project runs through July 31, 2030, with place of performance in Kansas City, Missouri. The research will create a...
- The National Institute of Child Health and Human Development, part of the Department of Health and Human Services National Institutes of Health, awarded the University of Rochester $580,341 on June 19, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.HDR) to conduct empirical research identifying the susceptibility mechanisms through which children's environmental sensitivity moderates the relationship between family functioning and psychological...
- The National Institute of Child Health and Human Development awarded Michigan State University $680,140 on July 13, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to examine how prenatal stress and early childhood risk and protective factors shape biopsychosocial development in middle childhood. The research leverages a longitudinal cohort of 374 mother-child dyads oversampled for life stress, with data collection beginning at gestation week 15...
- The National Institute of Child Health and Human Development awarded Children's Hospital Los Angeles $149,766 on July 1, 2026, under the Child Health and Human Development Extramural Research Projects program (CFDA 93.HDR) to conduct research on readiness potential as a neural correlate of motor planning in toddlers and young children. The project uses electroencephalography (EEG) and motion capture technology to identify and characterize readiness potential—a spike in brain activity preceding...
- The National Institute of Child Health and Human Development awarded Seattle Children's Hospital $5,031,656 on September 30, 2025, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to conduct longitudinal research examining how early life social determinants and sex-specific pubertal pathways contribute to the development of adolescent chronic pain. The project follows approximately 415 mother-child dyads across four sites in the United States through age 14,...
- The National Institute of Child Health and Human Development awarded The Trustees of Columbia University in the City of New York $167,400 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.865) to investigate the relationships between early relational health, maternal unpredictability, and infant adiposity as risk factors for early childhood obesity. The research will determine associations between early relational health constructs (including...
The National Institute of Child Health and Human Development awarded Children's Hospital Los Angeles $732,995 on September 1, 2026, to identify child risk and resilience factors in response to early life adversity and adverse childhood experiences under the Child Health and Human Development Extramural Research program (CFDA 93.865). The research develops scalable biological measures to augment existing questionnaire screening for early identification of toxic stress response in children exposed to early life adversity. The study examines mitochondrial genomic measures and oxidative stress markers derived from buccal swabs collected from a mother-child cohort expected to reach 340 dyads. Three different mitochondrial genomic measures combined with oxidative stress samples provide a readout of mitochondrial allostatic load to capture biological adaptation and resilience to early life adversity, representing an important component in assessing toxic stress risk beyond current pediatric ACES and PEARLS questionnaire screening tools. Performance occurs in Los Angeles, California, with a period of performance extending from September 1, 2026, through May 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $733.0k | 8/20/26 |